AAPL279.23-13.94 (-4.75%) ▼|ABBV241.70+6.81 (+2.90%) ▲|ABT94.14+3.65 (+4.03%) ▲|ACN128.24-0.91 (-0.70%) ▼|ADBE196.55-0.01 (0.00%) ▼|AMAT629.32+40.36 (+6.85%) ▲|AMD517.69-1.37 (-0.26%) ▼|AMGN358.10+6.71 (+1.91%) ▲|AMT168.62-5.84 (-3.35%) ▼|AMZN229.34-5.04 (-2.15%) ▼|AVGO380.10-1.98 (-0.52%) ▼|AXP351.83+9.27 (+2.70%) ▲|BA223.27+3.02 (+1.37%) ▲|BAC59.00+1.27 (+2.19%) ▲|BKNG180.41-0.87 (-0.48%) ▼|BLK989.17+6.57 (+0.67%) ▲|BMY56.05+1.05 (+1.90%) ▲|BNY147.64+4.08 (+2.84%) ▲|BRK-B492.95-1.87 (-0.38%) ▼|C147.15+3.56 (+2.48%) ▲|CAT1,044.90+50.45 (+5.07%) ▲|CL91.12-0.76 (-0.83%) ▼|CMCSA22.89+0.25 (+1.10%) ▲|COF208.91+8.43 (+4.20%) ▲|COP106.62-0.30 (-0.28%) ▼|COST942.64-18.33 (-1.91%) ▼|CRM151.26-1.50 (-0.98%) ▼|CSCO119.80+0.06 (+0.05%) ▲|CVS104.58+2.71 (+2.66%) ▲|CVX171.41-0.05 (-0.03%) ▼|DE623.98+23.23 (+3.87%) ▲|DHR195.72+6.85 (+3.63%) ▲|DIS101.17+0.05 (+0.05%) ▲|DUK127.11+0.58 (+0.46%) ▲|EMR146.30+4.86 (+3.44%) ▲|FDX326.53+9.70 (+3.06%) ▲|GD348.67+4.35 (+1.26%) ▲|GE377.19+11.31 (+3.09%) ▲|GEV1,091.37+33.72 (+3.19%) ▲|GILD125.51+0.36 (+0.29%) ▲|GM80.17+1.22 (+1.55%) ▲|GOOG342.04-2.99 (-0.87%) ▼|GOOGL342.28-3.00 (-0.87%) ▼|GS1,098.82+21.91 (+2.03%) ▲|HD347.71+4.85 (+1.41%) ▲|HON235.58+8.16 (+3.59%) ▲|IBM262.43-0.53 (-0.20%) ▼|INTC128.93-2.98 (-2.26%) ▼|INTU259.26-3.07 (-1.17%) ▼|ISRG409.22+7.39 (+1.84%) ▲|JNJ247.58+6.58 (+2.73%) ▲|JPM341.54+8.09 (+2.42%) ▲|KO80.63+0.03 (+0.03%) ▲|LIN525.23+9.50 (+1.84%) ▲|LLY1,139.69+22.43 (+2.01%) ▲|LMT508.84+17.20 (+3.50%) ▲|LOW224.24+2.79 (+1.26%) ▲|LRCX381.21+6.39 (+1.70%) ▲|MA501.56+7.15 (+1.45%) ▲|MCD269.00-4.88 (-1.78%) ▼|MDLZ62.36+0.62 (+1.00%) ▲|MDT82.22+2.09 (+2.61%) ▲|META553.99-3.81 (-0.68%) ▼|MMM168.99+3.08 (+1.86%) ▲|MO72.78+0.71 (+0.99%) ▲|MRK123.82+3.22 (+2.67%) ▲|MS226.00+6.14 (+2.79%) ▲|MSFT357.07-8.38 (-2.29%) ▼|MU1,157.57+109.65 (+10.46%) ▲|NEE87.68+0.06 (+0.06%) ▲|NFLX72.20+0.36 (+0.49%) ▲|NKE41.52-0.31 (-0.73%) ▼|NOW90.78-3.02 (-3.22%) ▼|NVDA194.41-4.51 (-2.26%) ▼|ORCL152.43-5.10 (-3.24%) ▼|PEP141.06-1.21 (-0.85%) ▼|PFE24.12+0.08 (+0.31%) ▲|PG149.38-2.67 (-1.75%) ▼|PLTR107.50-6.01 (-5.29%) ▼|PM179.59+2.28 (+1.29%) ▲|QCOM204.43+7.11 (+3.60%) ▲|RTX188.73+3.67 (+1.98%) ▲|SBUX103.21-0.31 (-0.30%) ▼|SCHW91.66+0.27 (+0.30%) ▲|SO96.13+0.35 (+0.37%) ▲|SPG225.53+3.38 (+1.52%) ▲|T22.55+0.18 (+0.80%) ▲|TMO511.08+18.88 (+3.84%) ▲|TMUS181.59+0.80 (+0.44%) ▲|TSLA375.91+0.45 (+0.12%) ▲|TXN310.20+7.09 (+2.34%) ▲|UBER72.90-0.95 (-1.29%) ▼|UNH414.50+8.70 (+2.14%) ▲|UNP267.00+7.04 (+2.71%) ▲|UPS108.83+2.69 (+2.53%) ▲|USB61.69+1.58 (+2.63%) ▲|V339.46+7.23 (+2.17%) ▲|VZ46.02+0.34 (+0.73%) ▲|WFC86.17+1.87 (+2.22%) ▲|WMT117.25-1.76 (-1.48%) ▼|XOM137.15+0.25 (+0.18%) ▲|AAPL279.23-13.94 (-4.75%) ▼|ABBV241.70+6.81 (+2.90%) ▲|ABT94.14+3.65 (+4.03%) ▲|ACN128.24-0.91 (-0.70%) ▼|ADBE196.55-0.01 (0.00%) ▼|AMAT629.32+40.36 (+6.85%) ▲|AMD517.69-1.37 (-0.26%) ▼|AMGN358.10+6.71 (+1.91%) ▲|AMT168.62-5.84 (-3.35%) ▼|AMZN229.34-5.04 (-2.15%) ▼|AVGO380.10-1.98 (-0.52%) ▼|AXP351.83+9.27 (+2.70%) ▲|BA223.27+3.02 (+1.37%) ▲|BAC59.00+1.27 (+2.19%) ▲|BKNG180.41-0.87 (-0.48%) ▼|BLK989.17+6.57 (+0.67%) ▲|BMY56.05+1.05 (+1.90%) ▲|BNY147.64+4.08 (+2.84%) ▲|BRK-B492.95-1.87 (-0.38%) ▼|C147.15+3.56 (+2.48%) ▲|CAT1,044.90+50.45 (+5.07%) ▲|CL91.12-0.76 (-0.83%) ▼|CMCSA22.89+0.25 (+1.10%) ▲|COF208.91+8.43 (+4.20%) ▲|COP106.62-0.30 (-0.28%) ▼|COST942.64-18.33 (-1.91%) ▼|CRM151.26-1.50 (-0.98%) ▼|CSCO119.80+0.06 (+0.05%) ▲|CVS104.58+2.71 (+2.66%) ▲|CVX171.41-0.05 (-0.03%) ▼|DE623.98+23.23 (+3.87%) ▲|DHR195.72+6.85 (+3.63%) ▲|DIS101.17+0.05 (+0.05%) ▲|DUK127.11+0.58 (+0.46%) ▲|EMR146.30+4.86 (+3.44%) ▲|FDX326.53+9.70 (+3.06%) ▲|GD348.67+4.35 (+1.26%) ▲|GE377.19+11.31 (+3.09%) ▲|GEV1,091.37+33.72 (+3.19%) ▲|GILD125.51+0.36 (+0.29%) ▲|GM80.17+1.22 (+1.55%) ▲|GOOG342.04-2.99 (-0.87%) ▼|GOOGL342.28-3.00 (-0.87%) ▼|GS1,098.82+21.91 (+2.03%) ▲|HD347.71+4.85 (+1.41%) ▲|HON235.58+8.16 (+3.59%) ▲|IBM262.43-0.53 (-0.20%) ▼|INTC128.93-2.98 (-2.26%) ▼|INTU259.26-3.07 (-1.17%) ▼|ISRG409.22+7.39 (+1.84%) ▲|JNJ247.58+6.58 (+2.73%) ▲|JPM341.54+8.09 (+2.42%) ▲|KO80.63+0.03 (+0.03%) ▲|LIN525.23+9.50 (+1.84%) ▲|LLY1,139.69+22.43 (+2.01%) ▲|LMT508.84+17.20 (+3.50%) ▲|LOW224.24+2.79 (+1.26%) ▲|LRCX381.21+6.39 (+1.70%) ▲|MA501.56+7.15 (+1.45%) ▲|MCD269.00-4.88 (-1.78%) ▼|MDLZ62.36+0.62 (+1.00%) ▲|MDT82.22+2.09 (+2.61%) ▲|META553.99-3.81 (-0.68%) ▼|MMM168.99+3.08 (+1.86%) ▲|MO72.78+0.71 (+0.99%) ▲|MRK123.82+3.22 (+2.67%) ▲|MS226.00+6.14 (+2.79%) ▲|MSFT357.07-8.38 (-2.29%) ▼|MU1,157.57+109.65 (+10.46%) ▲|NEE87.68+0.06 (+0.06%) ▲|NFLX72.20+0.36 (+0.49%) ▲|NKE41.52-0.31 (-0.73%) ▼|NOW90.78-3.02 (-3.22%) ▼|NVDA194.41-4.51 (-2.26%) ▼|ORCL152.43-5.10 (-3.24%) ▼|PEP141.06-1.21 (-0.85%) ▼|PFE24.12+0.08 (+0.31%) ▲|PG149.38-2.67 (-1.75%) ▼|PLTR107.50-6.01 (-5.29%) ▼|PM179.59+2.28 (+1.29%) ▲|QCOM204.43+7.11 (+3.60%) ▲|RTX188.73+3.67 (+1.98%) ▲|SBUX103.21-0.31 (-0.30%) ▼|SCHW91.66+0.27 (+0.30%) ▲|SO96.13+0.35 (+0.37%) ▲|SPG225.53+3.38 (+1.52%) ▲|T22.55+0.18 (+0.80%) ▲|TMO511.08+18.88 (+3.84%) ▲|TMUS181.59+0.80 (+0.44%) ▲|TSLA375.91+0.45 (+0.12%) ▲|TXN310.20+7.09 (+2.34%) ▲|UBER72.90-0.95 (-1.29%) ▼|UNH414.50+8.70 (+2.14%) ▲|UNP267.00+7.04 (+2.71%) ▲|UPS108.83+2.69 (+2.53%) ▲|USB61.69+1.58 (+2.63%) ▲|V339.46+7.23 (+2.17%) ▲|VZ46.02+0.34 (+0.73%) ▲|WFC86.17+1.87 (+2.22%) ▲|WMT117.25-1.76 (-1.48%) ▼|XOM137.15+0.25 (+0.18%) ▲|
26.5 C
New York
Thursday, June 25, 2026

Tag: sciences

Univest Securities, LLC Congratulates Client Houston American Energy Corp. on its Latest Acquisition of Abundia Global Impact Group, LLC

New York, July 01, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, is pleased to congratulate its client, Houston American Energy Corp. (“HUSA”) , on its recent acquisition of Abundia Global Impact Group, LLC (“AGIG”). The acquisition is positioned to create a leading company focused on converting waste plastics into high-value, drop-in low-carbon fuels and chemical products.

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....

Novo Holdings portfolio company Kate Farms acquired by Danone

Novo Holdings led Kate Farms' Series C financing in 2022 and supported its continued growth as the company's largest institutional investor Transaction highlights the Planetary...

RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...

Cold Jet Unlocks Significant New Revenue Opportunities for RNG Biomethane Sites Through Advanced Carbon Capture and Dry Ice Production

Cold Jet enables RNG biomethane sites to turn CO2 emissions into high-value dry ice, unlocking significant new revenue streams.

atai Life Sciences Announces $50 Million Private Placement Financing

Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1

AB Volvo: Björn Nykvist awarded the Håkan Frisinger Prize for Excellence in Transportation Research

GOTHENBURG, Sweden, July 1, 2025 /PRNewswire/ -- The Volvo Research and Educational Foundations (VREF) has awarded doctor Björn Nykvist, Senior Research Fellow and Team...

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced the closing of its underwritten public offering of 15,000,000 shares of its common stock and accompanying common warrants to purchase up to 16,766,666 shares of common stock at a public offering price of $3.00 per share and accompanying warrant, which includes common warrants to purchase up to 1,766,666 shares issued upon the partial exercise by the underwriters of their option to purchase additional shares of common stock and/or accompanying warrants. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, were $45.0 million.

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced the voting results on the items of business considered at the virtual annual general and special meeting of shareholders of the Company (the “AGSM”) held today.

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

Australian digital health leaders come together to enable solutions for overlooked health challenges: Winners announced

Apps tackling nutritional literacy in migrant communities and child sleep issues to be developed, co-designed, tested and delivered to target populations as part of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSciences